<DOC>
	<DOCNO>NCT00276952</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy Gonyautoxin 2/3 epimers treatment patient diagnose chronic tensional-type headache accordance International Headache Society guideline</brief_summary>
	<brief_title>Gonyautoxin Treatment Chronic Tension-Type Headache</brief_title>
	<detailed_description>Gonyautoxin phycotoxins , whose molecular mechanism action reversible block voltage-gated sodium channel neuronal level . They axonal conduction blocker impede nerve impulse propagation . In order evaluate clinical efficacy Gonyautoxin 2/3 epimers treatment patient diagnose chronic tensional-type headache , patient locally inject placebo versus Gonyautoxin follow painful spot injection standarized protocol</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Tension-Type Headache</mesh_term>
	<criteria>Chronic tensionaltype headache patient accord International Headache Society criterion : patient headache press tighten quality episodic frequency 15 day month Refractory conventional treatment , orally administer analgesic , systemic muscular relaxant , corticoid antidepressant like Amytriptiline Treated control University Hospital Neurology Clinic 2 year duration symptoms 3 year Pregnancy Use headache prophylactic treatment month prior infiltration Myasthenic syndromes Muscular dystrophy Inflammatory myopathy Acute chronic polineuropathies Use psychotropic substance 24hour infiltration Anticoagulant treatment terminal illness ( AIDS , cancer ) drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Gonyautoxins</keyword>
	<keyword>Tension-type Headache</keyword>
	<keyword>Human Treatment</keyword>
</DOC>